| Director Dealings Summary - Week Ended January 23 | ||||||||||||
| Company | Name | Position | Buy or Sell | Number of Shares | Resulting Holding | *Note | ||||||
| 1PM | Ron Russell | Non-Executive Director | Buy | 40,907 | 7.3 million | After posting positive results | ||||||
| Aberdeen Asset Management | Richard Mully | Non-Executive Director | Buy | 15,000 | 30,000 | |||||||
| Amati VCT | Paul Jourdan | Manager | Buy | 34,698 | 282,506 | |||||||
| Bankers Investment Trust | David Wild | Non-Executive Director | Buy | 8,403 | 12,803 | |||||||
| BlueRock Diamonds | John Kilham | CTO | Buy | 100,000 | 250,000 | |||||||
| British Land Co | Charles Maudsley | Director | Sold | 50,000 | Undisclosed | |||||||
| Cloudbuy | Lyn Duncan | CEO | Buy | 20,000 | 21.1 million | 2 weeks after signing new website deal | ||||||
| Enteq Upstream | David Steel | CFO | Buy | 12,659 | 81,240 | 3 days after profit warning | ||||||
| e-Therapeutics | Steve Medlicott | CFO | Buy | 150,000 | 250,000 | |||||||
| Flowgroup | Nigel Canham | CFO | Buy | 68,400 | 68,400 | First purchase | ||||||
| Fulcrum Utility Services | Stephen Gutteridge | Non-Executive Director | Buy | 125,000 | 529,166 | Week after deciding to take its operational delivery in-house | ||||||
| Games Workshop | Elaine O'Donnell | Non-Executive Director | Buy | 1,500 | 1,500 | First purchase | ||||||
| Hilton Food | Robert Watson | CEO | Sold | 90,000 | 2.9 million | 11 days after posting positive results | ||||||
| Judges Scientific | Alex Hambro | Chairman | Sold | 15,000 | 77,500 | Same day as company bought Armfield Ltd for GBP8.3 million | ||||||
| Kingfisher | Véronique Laury | CEO | Buy | 100,000 | Undisclosed | |||||||
| Mithril Capital | Rodger Sargent | Non-Executive Director | Buy | 675,000 | 5.4 million | |||||||
| Lamprell | John Macdonald | Senior Manager | Buy | 19,185 | 51,185 | 1 week after profit warning | ||||||
| Leed Resources | Charles Zorab | Non-Executive Director | Buy | 3.3 million | 3.3 million | 2 weeks after company agreed to invest in limestone miner | ||||||
| Lekoil | Gregory Eckersley | Non-Executive Director | Buy | 45,000 | 2.8 million | Same day as project in Nigeria declared "robust" | ||||||
| London Capital Group | Charles-Henri Sabet | Chairman | Buy | 250,000 | 1.7 million | Day after loan note conversions announced | ||||||
| Proton Power | Thomas Melczer | Business Development Director | Sold | 250,000 | 250,000 | 2 days after reporting a loss | ||||||
| REA Holdings | Irene Chia | Non-Executive Director | Buy | 1,000 | Undisclosed | |||||||
| Renew Holdings | Brian May | CEO | Sold | 350,000 | 494,193 | Sold from his wife's shareholding | ||||||
| Rosslyn Data Tech | Hugh Cox | Director | Buy | 38,838 | 9.5 million | Same day as company posted a loss | ||||||
| Shanta Gold | Luke Leslie | Non-Executive Director | Sold | 3.3 million | nil | Sold entire stake day after positive Q4 update | ||||||
| *Note: A recent company event around the time of the dealing does not suggest the dealing took place because of that event. | ||||||||||||
| When a spouse or related party to a director buys shares, the resulting holding is the beneficial holding of the director | ||||||||||||
| Contact: +44 207 199 0340; newsroom@alliancenews.com; @AllNewsTeam | ||||||||||||
| Copyright 2015 Alliance News Limited. All Rights Reserved. | ||||||||||||
2 Jul 2021 13:47
E-therapeutics meets 'key milestone' in Galapagos collaboration
(Sharecast News) - E-therapeutics has met a key milestone in its collaboration with Galapagos, a commercial-stage company specialising in the discovery and development of small-molecule medicines with novel modes of action, with a focus on inflammation, fibrosis and kidney disease, it announced on Friday.
Read more